NCT07435207

Brief Summary

The primary objective of the study is to evaluate the prevalence of blood prothrombotic factors in CRPS patients and their role in predicting response to neridronic acid treatment.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
11mo left

Started Jan 2026

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress37%
Jan 2026Jun 2027

Study Start

First participant enrolled

January 26, 2026

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

February 20, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 27, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

1 year

First QC Date

February 20, 2026

Last Update Submit

February 20, 2026

Conditions

Algoneurodystrophy

Outcome Measures

Primary Outcomes (1)

  • Pain VAS

    change in Pain VAS

    1,3 and 6 months after therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients affected by Algoneurodystrophy

You may qualify if:

  • patients aged 18 years or more

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione IRCCS Policlinico San Matteo di Pavia

Pavia, Pavia, 27100, Italy

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 20, 2026

First Posted

February 27, 2026

Study Start

January 26, 2026

Primary Completion (Estimated)

January 31, 2027

Study Completion (Estimated)

June 30, 2027

Last Updated

February 27, 2026

Record last verified: 2026-02

Locations

IT(1)